MidwesternDoc claims Gardasil risk on X
- An X account called MidwesternDoc circulated a Gardasil thread alleging higher cervical cancer risk after prior HPV infection, but public-health sources say the vaccine prevents new infections. - The Centers for Disease Control and Prevention says HPV vaccination does not treat existing infection; a 2025 CDC report found cervical precancers fell 80% in screened U.S. women ages 20 to 24. - The dispute landed against years of safety monitoring and falling precancer rates after vaccination. (cdc.gov)
Human papillomavirus, or HPV, is a common virus spread through sex, and some strains can cause cervical cancer years later. Gardasil is designed to block new HPV infections, not treat infections someone already has. (cdc.gov) (cancer.gov) That distinction sat at the center of a new X dispute after an account using the name MidwesternDoc posted a thread claiming Gardasil raises cervical cancer risk in people with prior HPV infection and accusing the Centers for Disease Control and Prevention of hiding it. The post itself was not independently accessible through web search, but the claim matched a familiar argument about vaccination after exposure. (cdc.gov) (cancer.gov) The Centers for Disease Control and Prevention says HPV vaccination “prevents new HPV infections” and “does not treat existing HPV infections or diseases.” The National Cancer Institute says people already infected with one HPV type can still benefit because the vaccine can protect against other types they have not acquired. (cdc.gov) (cancer.gov) The main real-world trend runs in the opposite direction of the X claim. In a February 2025 Morbidity and Mortality Weekly Report, the Centers for Disease Control and Prevention said cervical precancer rates among screened U.S. women ages 20 to 24 fell 79% for CIN2+ lesions and 80% for CIN3+ lesions from 2008 to 2022. (cdc.gov) The agency said that age group was the one most likely to have been vaccinated as children or adolescents after the vaccine was first recommended in 2006. Among screened women ages 25 to 29, the same report found CIN3+ rates fell 37% over the same period. (cdc.gov) Longer-term studies from Scandinavia also point the same way. The Centers for Disease Control and Prevention’s clinician summary says women vaccinated in their teens in Sweden and Denmark were later shown to have a lower risk of cervical cancer as adults. (cdc.gov) Another strand of the X pushback focused on fertility, a separate allegation that often travels with HPV-vaccine misinformation. A 2020 study in the journal Vaccine found no association between HPV vaccination and self-reported infertility in U.S. females ages 20 to 33. (pubmed.ncbi.nlm.nih.gov) (sciencedirect.com) The World Health Organization’s Global Advisory Committee on Vaccine Safety reviewed the infertility question and said the evidence does not suggest a causal relationship between HPV vaccination and infertility. Its review covered case reports, passive surveillance and epidemiological studies. (who.int) Gardasil 9 has been the only HPV vaccine used in the United States since late 2016, according to the Centers for Disease Control and Prevention. The agency says more than 15 years of monitoring and research show HPV vaccination provides safe, effective and long-lasting protection against cancers caused by HPV infections. (cdc.gov) The practical message from the evidence is narrower than the social-media fight. Vaccination works best before exposure, it does not erase an infection already present, and vaccinated people still need cervical cancer screening because the vaccine does not cover every cancer-causing HPV type. (cdc.gov) (cancer.gov) So the claim that Gardasil raises cervical cancer risk after prior HPV infection is not supported by the public-health evidence cited by U.S. and international health agencies. The measurable trend in the United States has been a steep drop in cervical precancers in the cohorts most likely to have been vaccinated. (cdc.gov 1) (cdc.gov 2)